Britain will invest 75 million pounds to eliminate animal experiments from scientific research through advanced technologies, including artificial organ systems, computational modeling and three-dimensional biological tissue fabrication. Science Minister Lord Vallance announced Tuesday that the program establishes timeframes to halt creature-based irritation assessments by late 2026 and substantially curtail primate pharmacokinetic studies by 2030.
Funding creates national coordination centers while directing 15.9 million pounds toward human cellular disease investigations spanning hepatic, neurological, oncological and cardiovascular conditions. The National Centre for the Replacement, Refinement and Reduction of Animals in Research will oversee implementation alongside representatives from pharmaceutical manufacturers and welfare organizations.
Medical research advocates cautioned that living subjects remain necessary where validated substitutes lack approval, though industry groups praised governmental commitment to ethical advancement. Cross-departmental oversight will publish performance measurements next year, tracking progress toward positioning the country as a leader in humane biotechnology development.
Funding creates national coordination centers while directing 15.9 million pounds toward human cellular disease investigations spanning hepatic, neurological, oncological and cardiovascular conditions. The National Centre for the Replacement, Refinement and Reduction of Animals in Research will oversee implementation alongside representatives from pharmaceutical manufacturers and welfare organizations.
Medical research advocates cautioned that living subjects remain necessary where validated substitutes lack approval, though industry groups praised governmental commitment to ethical advancement. Cross-departmental oversight will publish performance measurements next year, tracking progress toward positioning the country as a leader in humane biotechnology development.
